The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Glucose transporter type I deficiency syndrome: Epilepsy phenotypes and outcomes
Abstract
Summary: Purpose: Glut 1 deficiency syndrome (DS) is defined by hypoglycorrhachia with normoglycemia, acquired microcephaly, episodic movements, and epilepsy refractory to standard antiepileptic drugs (AEDs). Gold standard treatment is the ketogenic diet (KD), which provides ketones to treat neuroglycopenia. Our purpose is (1) to describe epilepsy phenotypes in a large Glut 1 DS cohort, to facilitate diagnosis; and (2) to describe cases in which non‐KD agents achieved seizure freedom (SF), highlighting potential adjunctive treatments. Methods: Retrospective review of 87 patients with Glut 1 DS (45% female, age range 3 months–35 years, average diagnosis 6.5 years) at Columbia University, from 1989 to 2010. Key Findings: Seventy‐eight (90%) of 87 patients had epilepsy, with average onset at 8 months. Seizures were mixed in 68% (53/78): generalized tonic–clonic (53%), absence (49%), complex partial (37%), myoclonic (27%), drop (26%), tonic (12%), simple partial (3%), and spasms (3%). We describe the first two cases of spasms in Glut 1 DS. Electrophysiologic abnormalities were highly variable over time; only 13 (17%) of 75 had exclusively normal findings. KD was used in 82% (64/78); 67% (41/61) were seizure‐free and 68% of seizure‐free patients (28/41) resolved in <1 week and 76% (31/41) in <1 month. Seven patients achieved SF with broad agents only. Significance: Glut 1 DS is a genetic metabolic encephalopathy with variable focal and multifocal seizure types and electroencephalographic findings. Infants with seizures, spasms, or paroxysmal events should be tested for Glut 1 DS. Evidence is insufficient to recommend specific AEDs as alternatives to KD. Early diagnosis and initiation of KD and prevention of unnecessary AED trials in Glut 1 DS are important goals for the treatment of children with epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chugani, H. T., & Phelps, M. E. (1986) · Science · doi:10.1126/science.3945811 · Cited by 663
Cited by
Zuberi, S. M., Wirrell, E., Yozawitz, E., Wilmshurst, J. M., Specchio, N., Riney, K., Pressler, R., Auvin, S., Samia, P., Hirsch, E., et al. (2022) · Epilepsia · doi:10.1111/epi.17239 · Cited by 934
Symonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., et al. (2019) · Brain · doi:10.1093/brain/awz195 · Cited by 459
The ketogenic diet: metabolic influences on brain excitability and epilepsy
Lutas, A., & Yellen, G. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.005 · Cited by 321
Klepper, J., Akman, C., Armeno, M., Auvin, S., Cervenka, M., Cross, H. J., De Giorgis, V., Della Marina, A., Engelstad, K., Heussinger, N., et al. (2020) · Epilepsia Open · doi:10.1002/epi4.12414 · Cited by 285
Self-citationTagliabue, A., Ferraris, C., Uggeri, F., Trentani, C., Bertoli, S., de Giorgis, V., Veggiotti, P., & Elli, M. (2017) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2016.11.003 · Cited by 126
Metadata
- Authors
- Pong, A. W., Geary, B. R., Engelstad, K. M., Natarajan, A., Yang, H., & De Vivo, D. C.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2012-07-19
- Volume
- 53
- Issue
- 9
- Pages
- 1503-1510
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1567755466
- Cited by
- 170
- References
- 1
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucose transporter type I deficiency syndrome: Epilepsy phenotypes and outcomes. https://app.cochat.ai/papers/10.1111/j.1528-1167.2012.03592.x
- The paper
- Pong, A. W., Geary, B. R., Engelstad, K. M., Natarajan, A., Yang, H., & De Vivo, D. C. (2012). Glucose transporter type I deficiency syndrome: Epilepsy phenotypes and outcomes. Epilepsia. https://doi.org/10.1111/j.1528-1167.2012.03592.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.